{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T12:04:30Z","timestamp":1769947470906,"version":"3.49.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T00:00:00Z","timestamp":1733097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T00:00:00Z","timestamp":1733097600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Strahlenther Onkol"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s00066-024-02328-1","type":"journal-article","created":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T19:44:19Z","timestamp":1733168659000},"page":"637-644","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["MR-guided online adaptive stereotactic body radiotherapy (MRgSBRT) of primary lung tumors and lung oligometastases"],"prefix":"10.1007","volume":"201","author":[{"given":"Gamze","family":"Ugurluer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neris","family":"Dincer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teuta Zoto","family":"Mustafayev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gorkem","family":"Gungor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmet Ufuk","family":"Abacioglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meric","family":"Sengoz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enis","family":"Ozyar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8435-8074","authenticated-orcid":false,"given":"Banu","family":"Atalar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,12,2]]},"reference":[{"key":"2328_CR1","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/1748-717X-9-210","volume":"9","author":"A Amini","year":"2014","unstructured":"Amini\u00a0A et\u00a0al (2014) Stereotactic body radiation therapy (SBRT) for lung cancer patients previously treated with conventional radiotherapy: a\u00a0review. Radiat Oncol 9:210","journal-title":"Radiat Oncol"},{"issue":"10185","key":"2328_CR2","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1016\/S0140-6736(18)32487-5","volume":"393","author":"DA Palma","year":"2019","unstructured":"Palma\u00a0DA et\u00a0al (2019) Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a\u00a0randomised, phase\u00a02, open-label trial. Lancet 393(10185):2051\u20132058","journal-title":"Lancet"},{"issue":"4","key":"2328_CR3","doi-asserted-by":"publisher","first-page":"iv1","DOI":"10.1093\/annonc\/mdx222","volume":"28","author":"PE Postmus","year":"2017","unstructured":"Postmus\u00a0PE et\u00a0al (2017) Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 28(4):iv1\u2013iv21","journal-title":"Ann Oncol"},{"key":"2328_CR4","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.ctrv.2016.03.001","volume":"45","author":"C Chargari","year":"2016","unstructured":"Chargari\u00a0C et\u00a0al (2016) Optimize and refine therapeutic index in radiation therapy: overview of a\u00a0century. Cancer Treat Rev 45:58\u201367","journal-title":"Cancer Treat Rev"},{"issue":"5","key":"2328_CR5","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1378\/chest.124.5.1946","volume":"124","author":"R Timmerman","year":"2003","unstructured":"Timmerman\u00a0R et\u00a0al (2003) Extracranial stereotactic radioablation: results of a\u00a0phase\u00a0I\u00a0study in medically inoperable stage\u00a0I non-small cell lung cancer. Chest 124(5):1946\u20131955","journal-title":"Chest"},{"issue":"1","key":"2328_CR6","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.radonc.2005.09.003","volume":"77","author":"J Wulf","year":"2005","unstructured":"Wulf\u00a0J et\u00a0al (2005) Dose-response in stereotactic irradiation of lung tumors. Radiother Oncol 77(1):83\u201387","journal-title":"Radiother Oncol"},{"issue":"7 Suppl 3","key":"2328_CR7","doi-asserted-by":"publisher","first-page":"S94","DOI":"10.1097\/JTO.0b013e318074de34","volume":"2","author":"H Onishi","year":"2007","unstructured":"Onishi\u00a0H et\u00a0al (2007) Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage\u00a0I non-small cell lung cancer: updated results of 257 patients in a\u00a0Japanese multi-institutional study. J\u00a0Thorac Oncol 2(7 Suppl 3):S94\u2013S100","journal-title":"J Thorac Oncol"},{"issue":"2","key":"2328_CR8","doi-asserted-by":"publisher","first-page":"e27","DOI":"10.1016\/j.prro.2015.09.012","volume":"6","author":"JM Haseltine","year":"2016","unstructured":"Haseltine\u00a0JM et\u00a0al (2016) Fatal complications after stereotactic body radiation therapy for central lung tumors abutting the proximal bronchial tree. Pract Radiat Oncol 6(2):e27\u2013e33","journal-title":"Pract Radiat Oncol"},{"issue":"1","key":"2328_CR9","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s13014-020-01599-z","volume":"15","author":"G Landry","year":"2020","unstructured":"Landry\u00a0G, Corradini\u00a0S, Belka\u00a0C (2020) Magnetic resonance-guided radiation therapy: the beginning of a\u00a0new era. Radiat Oncol 15(1):163","journal-title":"Radiat Oncol"},{"issue":"1","key":"2328_CR10","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s13014-019-1308-y","volume":"14","author":"S Corradini","year":"2019","unstructured":"Corradini\u00a0S et\u00a0al (2019) MR-guidance in clinical reality: current treatment challenges and future perspectives. Radiat Oncol 14(1):92","journal-title":"Radiat Oncol"},{"issue":"3","key":"2328_CR11","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.radonc.2018.07.025","volume":"129","author":"D Cusumano","year":"2018","unstructured":"Cusumano\u00a0D et\u00a0al (2018) Predicting tumour motion during the whole radiotherapy treatment: a\u00a0systematic approach for thoracic and abdominal lesions based on real time MR. Radiother Oncol 129(3):456\u2013462","journal-title":"Radiother Oncol"},{"issue":"1","key":"2328_CR12","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/1754-9485.12968","volume":"64","author":"S Chin","year":"2020","unstructured":"Chin\u00a0S et\u00a0al (2020) Magnetic resonance-guided radiation therapy: a\u00a0review. J\u00a0Med Imaging Radiat Oncol 64(1):163\u2013177","journal-title":"J Med Imaging Radiat Oncol"},{"issue":"9","key":"2328_CR13","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.3109\/0284186X.2015.1062541","volume":"54","author":"CE Noel","year":"2015","unstructured":"Noel\u00a0CE et\u00a0al (2015) Comparison of onboard low-field magnetic resonance imaging versus onboard computed tomography for anatomy visualization in radiotherapy. Acta Oncol 54(9):1474\u20131482","journal-title":"Acta Oncol"},{"issue":"8","key":"2328_CR14","doi-asserted-by":"publisher","first-page":"4078","DOI":"10.1118\/1.3438081","volume":"37","author":"SH Benedict","year":"2010","unstructured":"Benedict\u00a0SH et\u00a0al (2010) Stereotactic body radiation therapy: the report of AAPM task group 101. Med Phys 37(8):4078\u20134101","journal-title":"Med Phys"},{"issue":"5","key":"2328_CR15","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.clon.2022.02.010","volume":"34","author":"P Diez","year":"2022","unstructured":"Diez\u00a0P et\u00a0al (2022) UK 2022 consensus on normal tissue dose-volume constraints for oligometastatic, primary lung and hepatocellular carcinoma stereotactic ablative radiotherapy. Clin Oncol 34(5):288\u2013300","journal-title":"Clin Oncol"},{"issue":"15","key":"2328_CR16","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1200\/JCO.18.00622","volume":"37","author":"A Bezjak","year":"2019","unstructured":"Bezjak\u00a0A et\u00a0al (2019) Safety and efficacy of a\u00a0five-fraction stereotactic body radiotherapy schedule for centrally located non-small-cell lung cancer: NRG oncology\/RTOG 0813 trial. J\u00a0Clin Oncol 37(15):1316\u20131325","journal-title":"J Clin Oncol"},{"issue":"1","key":"2328_CR17","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.1016\/j.prro.2020.07.003","volume":"11","author":"G Gungor","year":"2021","unstructured":"Gungor\u00a0G et\u00a0al (2021) Time analysis of online adaptive magnetic resonance-guided radiation therapy workflow according to anatomical sites. Pract Radiat Oncol 11(1):e11\u2013e21","journal-title":"Pract Radiat Oncol"},{"key":"2328_CR18","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.radonc.2019.10.013","volume":"144","author":"T Finazzi","year":"2020","unstructured":"Finazzi\u00a0T et\u00a0al (2020) Stereotactic MR-guided adaptive radiation therapy for peripheral lung tumors. Radiother Oncol 144:46\u201352","journal-title":"Radiother Oncol"},{"issue":"3","key":"2328_CR19","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.ijrobp.2009.02.027","volume":"76","author":"NE Dunlap","year":"2010","unstructured":"Dunlap\u00a0NE et\u00a0al (2010) Chest wall volume receiving \u3009\u202f30\u202fGy predicts risk of severe pain and\/or rib fracture after lung stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys 76(3):796\u2013801","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"2328_CR20","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.ijrobp.2020.02.025","volume":"107","author":"T Finazzi","year":"2020","unstructured":"Finazzi\u00a0T et\u00a0al (2020) Clinical outcomes of stereotactic MR-guided adaptive radiation therapy for high-risk lung tumors. Int J Radiat Oncol Biol Phys 107(2):270\u2013278","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"2328_CR21","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.ijrobp.2019.03.035","volume":"104","author":"T Finazzi","year":"2019","unstructured":"Finazzi\u00a0T et\u00a0al (2019) Role of on-table plan adaptation in MR-guided ablative radiation therapy for central lung tumors. Int J Radiat Oncol Biol Phys 104(4):933\u2013941","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"2328_CR22","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.adro.2018.10.003","volume":"4","author":"LE Henke","year":"2019","unstructured":"Henke\u00a0LE et\u00a0al (2019) Stereotactic MR-guided online adaptive radiation therapy (SMART) for ultracentral thorax malignancies: results of a\u00a0phase\u00a01 trial. Adv Radiat Oncol 4(1):201\u2013209","journal-title":"Adv Radiat Oncol"},{"issue":"7","key":"2328_CR23","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1016\/j.jtho.2021.03.019","volume":"16","author":"K Lindberg","year":"2021","unstructured":"Lindberg\u00a0K et\u00a0al (2021) The HILUS-trial\u2014a prospective nordic multicenter phase\u00a02 study of ultracentral lung tumors treated with stereotactic body radiotherapy. J\u00a0Thorac Oncol 16(7):1200\u20131210","journal-title":"J Thorac Oncol"},{"key":"2328_CR24","doi-asserted-by":"crossref","unstructured":"Levy A et\u00a0al (2024) Stereotactic body radiotherapy for centrally located inoperable early-stage NSCLC: EORTC 22113\u201308113 lungtech phase\u00a0II trial results. J\u00a0Thorac Oncol","DOI":"10.1016\/j.jtho.2024.08.001"},{"issue":"3","key":"2328_CR25","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.ijrobp.2024.03.050","volume":"120","author":"ME Giuliani","year":"2024","unstructured":"Giuliani\u00a0ME et\u00a0al (2024) Stereotactic radiation for ultra-central non-small cell lung cancer: a\u00a0safety and efficacy trial (SUNSET). Int J Radiat Oncol Biol Phys 120(3):669\u2013677","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"2328_CR26","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.radonc.2017.11.032","volume":"126","author":"L Henke","year":"2018","unstructured":"Henke\u00a0L et\u00a0al (2018) Phase\u00a0I trial of stereotactic MR-guided online adaptive radiation therapy (SMART) for the treatment of oligometastatic or unresectable primary malignancies of the abdomen. Radiother Oncol 126(3):519\u2013526","journal-title":"Radiother Oncol"},{"key":"2328_CR27","doi-asserted-by":"publisher","first-page":"757031","DOI":"10.3389\/fonc.2021.757031","volume":"11","author":"S Regnery","year":"2021","unstructured":"Regnery\u00a0S et\u00a0al (2021) Adaptive MR-guided stereotactic radiotherapy is beneficial for ablative treatment of lung tumors in high-risk locations. Front Oncol 11:757031","journal-title":"Front Oncol"},{"key":"2328_CR28","first-page":"100736","volume":"45","author":"S Hering","year":"2024","unstructured":"Hering\u00a0S et\u00a0al (2024) The role of online MR-guided multi-fraction stereotactic ablative radiotherapy in lung tumours. Clin Transl Radiat Oncol 45:100736","journal-title":"Clin Transl Radiat Oncol"},{"key":"2328_CR29","first-page":"100744","volume":"45","author":"LG Merckel","year":"2024","unstructured":"Merckel\u00a0LG et\u00a0al (2024) Stereotactic body radiotherapy of central lung tumours using a\u00a01.5 T MR-linac: first clinical experiences. Clin Transl Radiat Oncol 45:100744","journal-title":"Clin Transl Radiat Oncol"},{"key":"2328_CR30","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.phro.2020.05.002","volume":"14","author":"T Finazzi","year":"2020","unstructured":"Finazzi\u00a0T et\u00a0al (2020) Delivery of magnetic resonance-guided single-fraction stereotactic lung radiotherapy. Phys Imaging Radiat Oncol 14:17\u201323","journal-title":"Phys Imaging Radiat Oncol"},{"issue":"4","key":"2328_CR31","first-page":"e2423","volume":"10","author":"KR Padgett","year":"2018","unstructured":"Padgett\u00a0KR et\u00a0al (2018) Feasibility of adaptive MR-guided Stereotactic body radiotherapy (SBRT) of lung tumors. Cureus 10(4):e2423","journal-title":"Cureus"},{"issue":"5","key":"2328_CR32","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/j.ijrobp.2018.12.041","volume":"103","author":"S Siva","year":"2019","unstructured":"Siva\u00a0S, Ball\u00a0DL (2019) Single fraction SBRT for early stage lung cancer-less is more? Int J Radiat Oncol Biol Phys 103(5):1085\u20131087","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2328_CR33","doi-asserted-by":"publisher","first-page":"109576","DOI":"10.1016\/j.radonc.2023.109576","volume":"182","author":"R Eufemon Cereno","year":"2023","unstructured":"Eufemon Cereno\u00a0R et\u00a0al (2023) Should organs at risk (OARs) be prioritized over target volume coverage in stereotactic ablative radiotherapy (SABR) for oligometastases? a\u00a0secondary analysis of the population-based phase\u00a0II SABR-5\u00a0trial. Radiother Oncol 182:109576","journal-title":"Radiother Oncol"},{"issue":"5","key":"2328_CR34","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/j.ijrobp.2022.01.002","volume":"114","author":"M Van Oirschot","year":"2022","unstructured":"Van Oirschot\u00a0M et\u00a0al (2022) Determining planning priorities for SABR for oligometastatic disease: a\u00a0secondary analysis of the SABR-COMET phase\u00a0II randomized trial. Int J Radiat Oncol Biol Phys 114(5):1016\u20131021","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"12","key":"2328_CR35","first-page":"e6457","volume":"11","author":"B Sahin","year":"2019","unstructured":"Sahin\u00a0B et\u00a0al (2019) First 500 fractions delivered with a\u00a0magnetic resonance-guided radiotherapy system: initial experience. Cureus 11(12):e6457","journal-title":"Cureus"},{"key":"2328_CR36","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.3389\/fonc.2020.01782","volume":"10","author":"M Sayan","year":"2020","unstructured":"Sayan\u00a0M et\u00a0al (2020) Patient-reported tolerance of magnetic resonance-guided radiation therapy. Front Oncol 10:1782","journal-title":"Front Oncol"},{"issue":"1","key":"2328_CR37","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13014-016-0747-y","volume":"12","author":"JM Edmund","year":"2017","unstructured":"Edmund\u00a0JM, Nyholm\u00a0T (2017) A\u00a0review of substitute CT generation for MRI-only radiation therapy. Radiat Oncol 12(1):28","journal-title":"Radiat Oncol"},{"issue":"4","key":"2328_CR38","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1002\/mp.12155","volume":"44","author":"X Han","year":"2017","unstructured":"Han\u00a0X (2017) MR-based synthetic CT generation using a\u00a0deep convolutional neural network method. Med Phys 44(4):1408\u20131419","journal-title":"Med Phys"}],"container-title":["Strahlentherapie und Onkologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-024-02328-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00066-024-02328-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-024-02328-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T13:46:45Z","timestamp":1748440005000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00066-024-02328-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,2]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["2328"],"URL":"https:\/\/doi.org\/10.1007\/s00066-024-02328-1","relation":{},"ISSN":["0179-7158","1439-099X"],"issn-type":[{"value":"0179-7158","type":"print"},{"value":"1439-099X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,2]]},"assertion":[{"value":"9 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"G.\u00a0Ugurluer, N.\u00a0Dincer, T.Z.\u00a0Mustafayev, G.\u00a0Gungor, M.U.\u00a0Abacioglu, M.\u00a0Sengoz, E.\u00a0Ozyar and B.\u00a0Atalar declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}